Avacincaptad pegol
Avacincaptad pegol, which is a pegylated aptamer, has garnered significant attention as a C5 complement inhibitor that may reduce inflammation-related retinal pigment epithelium (RPE) damage. Avacincaptad pegol caqn be used for the research of stargardt macular dystrophy (STGD1) and geographic atrophy (GA) [1][2].
Product Specifications
CAS Number
1613641-69-2
Product Name Alternative
Izervay
UNSPSC
12352208
Target
Complement System
Type
Oligonucleotides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/avacincaptad-pegol.html
Solubility
10 mM in DMSO
Smiles
[Avacincaptadpegol]
Molecular Weight
52603 (Approximately)
References & Citations
[1]Rehan M Hussain, et al. Stargardt macular dystrophy and evolving therapies. Expert Opin Biol Ther. 2018 Oct;18 (10) :1049-1059.|[2]Glenn J Jaffe, et al. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial. Ophthalmology. 2021 Apr;128 (4) :576-586.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
Launched
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6956803 1.0 µg DNA
Pcdh12 sgRNA CRISPR Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details 
P4256-31A 200 µg
Plasminogen Activator Inhibitor Type 1 (PAI 1) (HRP)
Sign In for Pricing
View Details